|
1
|
Liu F, Yang C, Li S, Wu X, Xue K, Zhou Y, Liang X, Cheng X, Shi Q, Su W. Design and biological features of platinum (II) complexes with 3-hydroxy-3-(Trifluoromethyl)cyclobutane-1,1-Dicarboxylate as a leaving ligand. Eur J Med Chem 2022; 242:114673. [PMID: 36049275 DOI: 10.1016/j.ejmech.2022.114673] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2022] [Revised: 08/06/2022] [Accepted: 08/08/2022] [Indexed: 11/04/2022]
Abstract
A series of platinum compounds 2a-5a and 2b-5b with fluoro-functional groups are designed and synthesized. Among them, complex 2b is the most effective agent with 3-hydroxy-3-(trifluoromethyl)cyclobutane-1,1-dicarboxylate as a leaving ligand, which showed better cytotoxic activity than compounds containing only CF3 or OH group at 3-position of cyclobutane-1,1-dicarboxylate. The water solubility of 2a is better than that of carboplatin (32 mg/mL vs. 16 mg/mL), and its antitumor activity on A549 is 4.6-fold higher than that of carboplatin. The IC50 value of 2b on A549 cells is 4.73 ± 0.64 μM, which is comparable to that of oxaliplatin and higher than that of carboplatin. Meanwhile, 2a and 2b are less toxic than oxaliplatin and cisplatin toward BEAS-2B cells. Moreover, 2a and 2b induce cell apoptosis in vitro by the Bax-Bcl-2-caspase-3 pathway and ferroptosis through inhibiting GPx-4 and elevating COX2. Results from in vivo experiment show that the inhibition rate of A549 xenograft tumor is cisplatin > 2b > oxaliplatin > 2a > carboplatin.
Collapse
Affiliation(s)
- Fengfan Liu
- National Engineering Research Center for Process Development of Active Pharmaceutical Ingredients, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, 310014, China.
| | - Chen Yang
- National Engineering Research Center for Process Development of Active Pharmaceutical Ingredients, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, 310014, China
| | - Shaoguang Li
- National Engineering Research Center for Process Development of Active Pharmaceutical Ingredients, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, 310014, China
| | - Xiaoqi Wu
- National Engineering Research Center for Process Development of Active Pharmaceutical Ingredients, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, 310014, China
| | - Keming Xue
- National Engineering Research Center for Process Development of Active Pharmaceutical Ingredients, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, 310014, China
| | - Yibo Zhou
- National Engineering Research Center for Process Development of Active Pharmaceutical Ingredients, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, 310014, China
| | - Xiaobing Liang
- National Engineering Research Center for Process Development of Active Pharmaceutical Ingredients, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, 310014, China
| | - Xiang Cheng
- National Engineering Research Center for Process Development of Active Pharmaceutical Ingredients, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, 310014, China
| | - Qiwen Shi
- National Engineering Research Center for Process Development of Active Pharmaceutical Ingredients, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, 310014, China.
| | - Weike Su
- National Engineering Research Center for Process Development of Active Pharmaceutical Ingredients, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, 310014, China.
| |
Collapse
|
|
2
|
Ionescu A, Caligiuri R, Godbert N, Ricciardi L, La Deda M, Ghedini M, Ferri N, Lupo MG, Facchetti G, Rimoldi I, Aiello I. Cytotoxic performances of new anionic cyclometalated Pt(II) complexes bearing chelated O^O ligands. Appl Organomet Chem 2020. [DOI: 10.1002/aoc.5455] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Affiliation(s)
- Andreea Ionescu
- MAT‐InLAB, LASCAMM CR‐INSTM, Unità INSTM della Calabria, Dipartimento di Chimica e Tecnologie ChimicheUniversità della Calabria Ponte Pietro Bucci Cubo 14C 87036 Arcavacata di Rende (CS) Italy
- CNR NANOTEC‐Istituto di Nanotecnologia UOS Cosenza 87036 Arcavacata di Rende (CS) Italy
| | - Rossella Caligiuri
- MAT‐InLAB, LASCAMM CR‐INSTM, Unità INSTM della Calabria, Dipartimento di Chimica e Tecnologie ChimicheUniversità della Calabria Ponte Pietro Bucci Cubo 14C 87036 Arcavacata di Rende (CS) Italy
| | - Nicolas Godbert
- MAT‐InLAB, LASCAMM CR‐INSTM, Unità INSTM della Calabria, Dipartimento di Chimica e Tecnologie ChimicheUniversità della Calabria Ponte Pietro Bucci Cubo 14C 87036 Arcavacata di Rende (CS) Italy
- CNR NANOTEC‐Istituto di Nanotecnologia UOS Cosenza 87036 Arcavacata di Rende (CS) Italy
| | - Loredana Ricciardi
- CNR NANOTEC‐Istituto di Nanotecnologia UOS Cosenza 87036 Arcavacata di Rende (CS) Italy
| | - Massimo La Deda
- MAT‐InLAB, LASCAMM CR‐INSTM, Unità INSTM della Calabria, Dipartimento di Chimica e Tecnologie ChimicheUniversità della Calabria Ponte Pietro Bucci Cubo 14C 87036 Arcavacata di Rende (CS) Italy
- CNR NANOTEC‐Istituto di Nanotecnologia UOS Cosenza 87036 Arcavacata di Rende (CS) Italy
| | - Mauro Ghedini
- MAT‐InLAB, LASCAMM CR‐INSTM, Unità INSTM della Calabria, Dipartimento di Chimica e Tecnologie ChimicheUniversità della Calabria Ponte Pietro Bucci Cubo 14C 87036 Arcavacata di Rende (CS) Italy
- CNR NANOTEC‐Istituto di Nanotecnologia UOS Cosenza 87036 Arcavacata di Rende (CS) Italy
| | - Nicola Ferri
- Dipartimento di Scienze del FarmacoUniversità degli Studi di Padova Via Marzolo 5 35131 Padua Italy
| | - Maria Giovanna Lupo
- Dipartimento di Scienze del FarmacoUniversità degli Studi di Padova Via Marzolo 5 35131 Padua Italy
| | - Giorgio Facchetti
- Dipartimento di Scienze FarmaceuticheUniversità degli Studi di Milano Via Venezian 21 20133 Milan Italy
| | - Isabella Rimoldi
- Dipartimento di Scienze FarmaceuticheUniversità degli Studi di Milano Via Venezian 21 20133 Milan Italy
| | - Iolinda Aiello
- MAT‐InLAB, LASCAMM CR‐INSTM, Unità INSTM della Calabria, Dipartimento di Chimica e Tecnologie ChimicheUniversità della Calabria Ponte Pietro Bucci Cubo 14C 87036 Arcavacata di Rende (CS) Italy
- CNR NANOTEC‐Istituto di Nanotecnologia UOS Cosenza 87036 Arcavacata di Rende (CS) Italy
| |
Collapse
|